Article Details
Retrieved on: 2022-08-12 15:40:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The mutations in Omicron's spike protein have reduced the efficacy of SARS-CoV-2 vaccines and therapeutic monoclonal antibodies (mAbs).
Article found on: upjobsnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here